Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthesis of New Shogaol Analogues as NRF2 Activators and Evaluation of Their Anti-Inflammatory Activity, Modes of Action and Metabolic Stability. | Antioxidants (Basel) | 2023 | 36830033 | PubTator, text mining | PubMed |
| The Complex Genetic and Epigenetic Regulation of the Nrf2 Pathways: A Review. | Antioxidants (Basel) | 2023 | 36829925 | PubTator, text mining | PubMed |
| The Effect of Carnosine on UVA-Induced Changes in Intracellular Signaling of Human Skin Fibroblast Spheroids. | Antioxidants (Basel) | 2023 | 36829859 | PubTator, text mining | PubMed |
| Exploring functional and structural features of chemically related natural prenylated hydroquinone and benzoic acid from Piper crassinervium (Piperaceae) on bacterial peroxiredoxin inhibition. | PLoS One | 2023 | 36827425 | PubTator, text mining | PubMed |
| Importance of Metal Biotransformation in Cell Response to Metallic Nanoparticles: A Transcriptomic Meta-analysis Study. | ACS Nanosci Au | 2023 | 36820094 | PubTator, text mining | PubMed |
| Pregnancy outcomes and newborn characteristics in women with follicular fluid thyroid autoantibodies undergoing assisted reproduction. | J Med Biochem | 2023 | 36819134 | PubTator, text mining | PubMed |
| Editorial: Small molecule inhibitors targeting mammalian selenoprotein thioredoxin reductases (TXNRDs): Interactions, mechanisms, and applications. | Front Mol Biosci | 2023 | 36818046 | PubTator, text mining | PubMed |
| Yield and Properties Prediction Based on the Multicondition LSTM Model for the Solvent Deasphalting Process. | ACS Omega | 2023 | 36816643 | PubTator, text mining | PubMed |
| Editorial: Pulmonary hypertension in the modern era: Science and clinical practice, Volume II. | Front Med (Lausanne) | 2023 | 36814774 | PubTator, text mining | PubMed |
| Identification and validation of ferroptosis-related gene signature in intervertebral disc degeneration. | Front Endocrinol (Lausanne) | 2023 | 36814575 | PubTator, text mining | PubMed |
| Effect of evernic acid on human breast cancer MCF-7 and MDA-MB-453 cell lines via thioredoxin reductase 1: A molecular approach. | J Appl Toxicol | 2023 | 36807289 | PubTator, text mining | PubMed |
Withdrawn: 'Downregulation of circPPFIA1 elevates radiosensitivity via miR-1299-mediated TXNRD1 inhibition in oesophageal squamous cell carcinoma', Weihui Yu, Ke Ning, Jincheng Xiao, Qiwen Bai and Chenyang Guo. (https://onlinelibrary.wiley.com/doi/10.1111/1440-1681.13751). | Clin Exp Pharmacol Physiol | 2023 | 36797846 | PubTator, text mining | PubMed |
| Emerging landscape of circFNDC3B and its role in human malignancies. | Front Oncol | 2023 | 36793611 | PubTator, text mining | PubMed |
| Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review). | Exp Ther Med | 2023 | 36793330 | PubTator, text mining | PubMed |
| An in vitro approach to understand contribution of kidney cells to human urinary extracellular vesicles. | J Extracell Vesicles | 2023 | 36785873 | PubTator, text mining | PubMed |
| Thimerosal, a competitive thioredoxin reductase 1 (TrxR1) inhibitor discovered via high-throughput screening. | Biochem Biophys Res Commun | 2023 | 36780763 | PubTator, text mining | PubMed |
| NADPH oxidase 1 in chronic pancreatitis-activated pancreatic stellate cells facilitates the progression of pancreatic cancer. | Am J Cancer Res | 2023 | 36777508 | PubTator, text mining | PubMed |
| Identification of thioredoxin-1 as a biomarker of lung cancer and evaluation of its prognostic value based on bioinformatics analysis. | Front Oncol | 2023 | 36776308 | PubTator, text mining | PubMed |
| Glutathione-Related Enzymes and Proteins: A Review. | Molecules | 2023 | 36771108 | PubTator, text mining | PubMed |
| A Review of Plant Selenium-Enriched Proteins/Peptides: Extraction, Detection, Bioavailability, and Effects of Processing. | Molecules | 2023 | 36770890 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=38